Update rising PSA in Off phase of IAD
An update on my rising PSA in my “off” phase of IAD treatment.
After 11 months into my “off” phase in 05/13 my PSA rose from <0.008 to 0.022.
In 06/13 it had risen to 0.065 a doubling time of 22 days.
Today 30/7/13 it has risen to 0.098 a doubling time of 79 days
This slowing is consistent with the relapse that occurred post RP and post SRT an initial burst and then a slowing. I am hoping it will continue to slow and stabilise at a rate in excess of 4 months PSADT
In addition My CTC (circulating tumour cell) count remains at 1 which has not changed for over 20 months.
I agreed with my Oncologist that there is no point in undertaking a scan at this stage a) the PSA reading is too low to expect anything to show on a scan and b) we agreed to review where the PSADT sits in 8 weeks’ time and review again then.
I have embarked on a more rigorous exercise program now walking 80-100km per week, swimming twice a week and doing weights twice a week. I have shed 4kg in the last 6 weeks and need to lose 12kg more to get back to an ideal weight (75kg) for my height 1.77m .this is my target for Q1 2014, I was 80kg before I started IAD and have struggled to shed weight so I decided it was time for more rigorous and disciplined approach.
I have a 4 week vacation planned in France in late Aug so it will be a real test of will not to give in the temptation French wine and food that will be present in abundance and I am not sure I will succeed!!.
I will post an update in late September on both my PSA and weight!
Best wishes to all in your continued fight with the Bandit
Background;
DX ; (Gleason 7 (3+4)) RP in 02/2008
Relapse 11/08 rising PSA reaching 1 by 01/2009 when I undertook SRT , PSA fell to <0.03 by 04/2009 but started to rise again in 08/2010 with a PSADT of 2 months.
In June 2011 (aged 60) I started CAB my PSA was 1 at that time, prior to the start of hormone treatment I undertook PET/CT scans all of which were clear.
I had 3 monthly shots of Zoladex , and took Casodex and Proscar daily, my PSA dropped to 0.04 within 30 days and <0.008 in 60 days and Testosterone to castrate levels in 90 days.
I followed this program for 1 year, along the way I took daily supplements of vitamin D, Curcumin, Pomegranate, Omega 3, and resveratrol.
At the end of 1 year (06/2012) I dropped back to just Proscar, along with the supplements and started taking Celebrex daily and started Luekine injections, 14 days on 14 days off.
My testosterone took 9 months to recover and my PSA remained <0.008 until May 2013 (11 months off)
Comments
-
Great post
traveler,
Thx for a very informative post that surely will be helpful to other travelers following a similar PCa journey.
Have a wonderful time in France. Enjoy the fine wine, food, croissants, café au lait, etc....all in moderation, of courseGood luck on both journeys. Most importantly, be well.0 -
Update rising PSA in Off phase of IAD
An update on my latest test results, by way of background i finished my "on phase" in June 2012 and was undetectable until May 2013 when PSA rose to 0.022, it went to 0.065 in June and 0.095 in July doubling times of circa 21 days ,then 2.5 months, unfortunatley my test on the 26th September was 0.37 so a big jump almost a fourfold increase in 59 days. So as you can see the bandit is back with a vengence.
I am being philosophical about it, i will wait for another 6 weeks and see if it remains on an aggressive growth path but my "on phase" looms large and much earlier than i had hoped for. My Oncologist and i are debating what the right number is to restart and or when and if to have scans if we restart under a PSA of 2.
I will keep you posted on what the number look like in mid November.
0 -
Striking birdies
Traveler
I know your feelings and I am sorry for the increase. I think that you should consider getting another PET/MRI before starting HT. The threshold of your doctor should consider the latest capabilities of the modern equipments.
I take our cases as similar with similar paths (and ages). Your treatment protocol has been different than mine but the clock to re-starting ADT may have equal assessments.
My oncologist has set me to re-start ADT at a threshold PSA of 2.5. In any case he is not considering any possibility on cure. He takes me as systemic and disregarded the worthiness of any image study.
I think that he is out of touch with the latest methodologies and theories on the Oligometastatic cases. There are already enough “materials” to plan a series of tests to look for and find the cancer. My opinion is that we should try to get the upmost benefit of the latest’s examinations. ADT will do the job again if we lay down T to castrate, no matter in which level the PSA is at the re-start if it is under the 10th mark.I have recently talked with the radiologist of my SRT to get details on the RT protocol (areas and Gy level) he did back in 2006 to access any possibility in radiating over the same areas again. For my surprise he told me that they are also doing these latest tests with the C11 choline to find cancerous tissues. He commented about the relationship between the fast increases of PSA (short PSADT) which is related to periodical inflammations of the lymphatic nodes.
The practical theory is that our body fights the cancerous cells once these get into the lymphs and react against the “immune-cleaners” (anecdotally, they do not want to be turned into trash materials). The fight causes temporary inflammation, big enough in size to be detected by a scanner, and it promotes the cells to expel more PSA serum.
Accordingly, the condition could serve as the trigger for a C11 PET/MRI scan, even at low levels of PSA. In any case, I think that these tests should be done at more practical higher levels of PSA closer to the 4 ng/ml marker.In the past, famous oncologists would suggest re-starts of ADT with trigger levels of up to PSA=10.00ng/ml. The traditional was a PSA=5 to aggressive cases and PSA=10 to cases with history of indolence. However, this included all guys indiscriminately of previous treatments. (with or without the prostate)
A famous G7 patient, this year on his 14Th year of survival, who chosen IADT as his only and solo therapy (prostate in place), now with three Off periods accomplished, reported to re-start ADT at PSA level of 10. He also had fast increases of PSA at the fourth month point when the effects of Celebrex or Thalidomide stopped.
He managed to have vacations periods of over 20 months, before reaching the PSA of 10. His T level increased to high numbers of 800 (8.0 ng/ml).I believe that continuous IADT protocols are the perfect treatment for systemic cases but one must be properly diagnosed as Systemic with the best available methods at that particular time, because “things and methods” change to adopt the newer ways. I think you could explore conditions for the USPIO and the F18-FACBC PET, discussing it with Tucker in your next meeting.
Best wishes for many “birdie winning” games in this “long course” of your journey.
Regards
VGama
0 -
wise wordsVascodaGama said:Striking birdies
Traveler
I know your feelings and I am sorry for the increase. I think that you should consider getting another PET/MRI before starting HT. The threshold of your doctor should consider the latest capabilities of the modern equipments.
I take our cases as similar with similar paths (and ages). Your treatment protocol has been different than mine but the clock to re-starting ADT may have equal assessments.
My oncologist has set me to re-start ADT at a threshold PSA of 2.5. In any case he is not considering any possibility on cure. He takes me as systemic and disregarded the worthiness of any image study.
I think that he is out of touch with the latest methodologies and theories on the Oligometastatic cases. There are already enough “materials” to plan a series of tests to look for and find the cancer. My opinion is that we should try to get the upmost benefit of the latest’s examinations. ADT will do the job again if we lay down T to castrate, no matter in which level the PSA is at the re-start if it is under the 10th mark.I have recently talked with the radiologist of my SRT to get details on the RT protocol (areas and Gy level) he did back in 2006 to access any possibility in radiating over the same areas again. For my surprise he told me that they are also doing these latest tests with the C11 choline to find cancerous tissues. He commented about the relationship between the fast increases of PSA (short PSADT) which is related to periodical inflammations of the lymphatic nodes.
The practical theory is that our body fights the cancerous cells once these get into the lymphs and react against the “immune-cleaners” (anecdotally, they do not want to be turned into trash materials). The fight causes temporary inflammation, big enough in size to be detected by a scanner, and it promotes the cells to expel more PSA serum.
Accordingly, the condition could serve as the trigger for a C11 PET/MRI scan, even at low levels of PSA. In any case, I think that these tests should be done at more practical higher levels of PSA closer to the 4 ng/ml marker.In the past, famous oncologists would suggest re-starts of ADT with trigger levels of up to PSA=10.00ng/ml. The traditional was a PSA=5 to aggressive cases and PSA=10 to cases with history of indolence. However, this included all guys indiscriminately of previous treatments. (with or without the prostate)
A famous G7 patient, this year on his 14Th year of survival, who chosen IADT as his only and solo therapy (prostate in place), now with three Off periods accomplished, reported to re-start ADT at PSA level of 10. He also had fast increases of PSA at the fourth month point when the effects of Celebrex or Thalidomide stopped.
He managed to have vacations periods of over 20 months, before reaching the PSA of 10. His T level increased to high numbers of 800 (8.0 ng/ml).I believe that continuous IADT protocols are the perfect treatment for systemic cases but one must be properly diagnosed as Systemic with the best available methods at that particular time, because “things and methods” change to adopt the newer ways. I think you could explore conditions for the USPIO and the F18-FACBC PET, discussing it with Tucker in your next meeting.
Best wishes for many “birdie winning” games in this “long course” of your journey.
Regards
VGama
Vasco,
as always wise counsel.
I will look into the scans you have mentioned so that i am up to speed when i next meet Dr Tucker.
I also received my CTC result yesterday, this has fluxuated between 0 and 1 for the last 18 months and jumped to 7 this time, 5 is the cut off point above which metastatic disease is evident. I think one of the good things about the jump is i beleive it is clearly testosterone driven, my T score has jumped from castrate levels in June 2012 and 1 in Feb this yr to 22.4 in the last test so it is fair to assume that when i go to "on phase" my PSA should drop again.
I agree with you that it would be good to be able to identify the bandits location.
More research to do!!
Many thanks for you detailed response.
Traveler
0 -
Bandit spotted:traveler said:wise words
Vasco,
as always wise counsel.
I will look into the scans you have mentioned so that i am up to speed when i next meet Dr Tucker.
I also received my CTC result yesterday, this has fluxuated between 0 and 1 for the last 18 months and jumped to 7 this time, 5 is the cut off point above which metastatic disease is evident. I think one of the good things about the jump is i beleive it is clearly testosterone driven, my T score has jumped from castrate levels in June 2012 and 1 in Feb this yr to 22.4 in the last test so it is fair to assume that when i go to "on phase" my PSA should drop again.
I agree with you that it would be good to be able to identify the bandits location.
More research to do!!
Many thanks for you detailed response.
Traveler
Since I last updated you on my PC post the IAD off period started my PSA results have been as follows.
· On Sept 30th my PSA was 0.37
· On Oct 29th it was 0.791
· On Nov 27th it was 1.391
· On Dec 13th it was 1.563.
This shows a doubling time of circa 1 month so very aggressive.
I had agreed with my Oncologist that we would do a scan on Dec 13th also and we have decided that I will restart IAD on Mon 16th Dec with 3 month Zoladex , Proscar and instead of Casodex we will try Xtandi this time given the great results it appears to be having.
I got the results of the scans today (the scan we opted for was a F18 Fluromethycholine PET/CT study) the results identified an area approx. SUV 7.7IM 2-186 on left Ischium (in the pelvis) interestingly this is the same spot where something was identified in a scan I had at Sloane Kettering in 2011 but it was to small to be certain of its type or nature.
Although I was due to see my Oncologist on Monday he contacted me today (Sat) and asked me to call him. He feels we should go for targeted radiation to this spot as well as restart the IAD. I am both excited and nervous. Excited because we have identified where the PC is ,nervous because I have had salvage radiation therapy and worried about Rads on Rads. My oncologist seems positive that because this in not in the prostate bed that they can target this area safely but he wants time to review the best option on where to undertake this. As I feel this is a one shot opportunity I really want to get the best advice and find the best location to have this undertaken.
I remain concerned about damage to bladder or rectum from radiation given these would have been hit with the salvage radiation therapy after biochemical relapse post RP.
Any information anyone has about the best-equipped clinic/ latest equipment for targeted radiotherapy and or radiologist who has the best reputation please pass on your information it is gratefully received.
I also am a realist and no that this may just be the largest of a number of micro mets not yet identifiable.
I can see that a lot of research will be undertaken over the festive season.
More will be posted after my consultation on Monday.
0 -
next stepstraveler said:Bandit spotted:
Since I last updated you on my PC post the IAD off period started my PSA results have been as follows.
· On Sept 30th my PSA was 0.37
· On Oct 29th it was 0.791
· On Nov 27th it was 1.391
· On Dec 13th it was 1.563.
This shows a doubling time of circa 1 month so very aggressive.
I had agreed with my Oncologist that we would do a scan on Dec 13th also and we have decided that I will restart IAD on Mon 16th Dec with 3 month Zoladex , Proscar and instead of Casodex we will try Xtandi this time given the great results it appears to be having.
I got the results of the scans today (the scan we opted for was a F18 Fluromethycholine PET/CT study) the results identified an area approx. SUV 7.7IM 2-186 on left Ischium (in the pelvis) interestingly this is the same spot where something was identified in a scan I had at Sloane Kettering in 2011 but it was to small to be certain of its type or nature.
Although I was due to see my Oncologist on Monday he contacted me today (Sat) and asked me to call him. He feels we should go for targeted radiation to this spot as well as restart the IAD. I am both excited and nervous. Excited because we have identified where the PC is ,nervous because I have had salvage radiation therapy and worried about Rads on Rads. My oncologist seems positive that because this in not in the prostate bed that they can target this area safely but he wants time to review the best option on where to undertake this. As I feel this is a one shot opportunity I really want to get the best advice and find the best location to have this undertaken.
I remain concerned about damage to bladder or rectum from radiation given these would have been hit with the salvage radiation therapy after biochemical relapse post RP.
Any information anyone has about the best-equipped clinic/ latest equipment for targeted radiotherapy and or radiologist who has the best reputation please pass on your information it is gratefully received.
I also am a realist and no that this may just be the largest of a number of micro mets not yet identifiable.
I can see that a lot of research will be undertaken over the festive season.
More will be posted after my consultation on Monday.
Further to my last posting : i met with my Oncologist today and we agreed that radiating the Met found on my left Ischium makes sense. I restarted HT today with Zoladex (3 month shot) and Xtandi, we will aim to radiate in March before my next shot.We had a wide ranging discussion on options available and there are a number to be considered, In the mean time my Oncologist is going to research the options we discussed further, and also ascertain if we need to map the area now (beyond what is shown in the PET/CT scan) ahead of any future treatment as obviously come March it is unlikley the Met visable today will be able to be seen on a scan if the HT is working.We are going to discuss options as information becomes available to assess but we aim to lock in a plan by mid Jan. It looks like i will head to the US for the next phase of treatment.
As we go through our evaluation process i will post thoughts / discussions had and invite comments suggestions.
Many thanks
T
0 -
World class ROtraveler said:next steps
Further to my last posting : i met with my Oncologist today and we agreed that radiating the Met found on my left Ischium makes sense. I restarted HT today with Zoladex (3 month shot) and Xtandi, we will aim to radiate in March before my next shot.We had a wide ranging discussion on options available and there are a number to be considered, In the mean time my Oncologist is going to research the options we discussed further, and also ascertain if we need to map the area now (beyond what is shown in the PET/CT scan) ahead of any future treatment as obviously come March it is unlikley the Met visable today will be able to be seen on a scan if the HT is working.We are going to discuss options as information becomes available to assess but we aim to lock in a plan by mid Jan. It looks like i will head to the US for the next phase of treatment.
As we go through our evaluation process i will post thoughts / discussions had and invite comments suggestions.
Many thanks
T
T,My recommendation for a world class RO with expertise in secondary salvage focal RT (following previous failed RP & SRT) would be Dr Chris King at UCLA (California, USA)If there is any one, well respected & highly regarded RO in the USA who can evaluate whether the location of your mets can be safely and effectively tx'd while avoiding collateral tissue damage using SBRT or IMRT, my belief is that it's Dr King. He may or may not order a C11 Choline PET/CT to compare/confirm imaging results of both studies. UCLA offers the C11 acetate PET/CT. As you may know, for best C11 imaging, preferred PSA should be =/>2.0 & patient free of AD drugs.Wondering if you might share some add'l details about your recent and previous imaging studies. Presuming your Fluromethycholine PET/CT imaging was undertaken during IADT "vacation" status, what was your PSA just prior to the Fluromethycholine PET/CT imaging. What are the false positive/false negative rates of that image study? How long (time interval) from date of last ADT 3-mo injection and discontinuation of all triple ADT until actual imaging was performed? Why did you/your MO elect the F18 Fluromethycholine PET/CT vs the anti-3-[18F]FACBC PET/CT vs other advanced imaging contrast agent(s). Has an F-18 Na (sodium) PET/CT been performed? Which previous diagnostic imaging studies have you had and how long ago. Would you mind sharing at which medical institution (outside USA?) your recent imaging study was performed. Thanks.
Best of luck as you go forward.0 -
SUV 7.7 in cancer producing low serum PSAmrspjd said:World class RO
T,My recommendation for a world class RO with expertise in secondary salvage focal RT (following previous failed RP & SRT) would be Dr Chris King at UCLA (California, USA)If there is any one, well respected & highly regarded RO in the USA who can evaluate whether the location of your mets can be safely and effectively tx'd while avoiding collateral tissue damage using SBRT or IMRT, my belief is that it's Dr King. He may or may not order a C11 Choline PET/CT to compare/confirm imaging results of both studies. UCLA offers the C11 acetate PET/CT. As you may know, for best C11 imaging, preferred PSA should be =/>2.0 & patient free of AD drugs.Wondering if you might share some add'l details about your recent and previous imaging studies. Presuming your Fluromethycholine PET/CT imaging was undertaken during IADT "vacation" status, what was your PSA just prior to the Fluromethycholine PET/CT imaging. What are the false positive/false negative rates of that image study? How long (time interval) from date of last ADT 3-mo injection and discontinuation of all triple ADT until actual imaging was performed? Why did you/your MO elect the F18 Fluromethycholine PET/CT vs the anti-3-[18F]FACBC PET/CT vs other advanced imaging contrast agent(s). Has an F-18 Na (sodium) PET/CT been performed? Which previous diagnostic imaging studies have you had and how long ago. Would you mind sharing at which medical institution (outside USA?) your recent imaging study was performed. Thanks.
Best of luck as you go forward.Traveler
Thanks for the update. I am very curious and interested in your follow-ups because, though differently, I am behind you on the same “route” of testing and treatment (if I can afford it). Please excuse my opinions if they do not correspond to your decisions. In any case I accept your challenging invitation for comments and suggestions.
I think that you did well in starting your next phase of treatment because of your Gs7 and past PSA histology and events. However, the PSA level of 1.5 may have been too low (the threshold) to get the F18 FCH PET. Probably you may have reflected differently if the aggressivity was lower.
I see a series of facts that in my case with a diagnosed Gs6 I will consider before advancing with the PET/CT. One is the curve of the PSA. Sudden rises do not mean bigger volumes that may accommodate better scanning. A constant level is more indicative of volumetric tumours.
As you commented, the F18 Fluoromethyl choline PET/CT study (F18 FCH) got limits in detecting smaller volumes of malignancy (micromets). Studies show that this choline analogue (fluorocholine) manages to pinpoint volumes with a mean SUVmax between 6.0 to 2.0. But benign tissues that can produce SUV of 4.0 may cause false positives in the presence of malignancies of lower SUV 2.0.
Your test revealed an area with SUV 7.7 which may be judged extraordinary elevated for a low PSA of 1.5. This tells me that your cancer cells are of the type that uptake well the contrast agent even in the low PSA “environment”. The fact takes me to believe that the “whole” existing cancer resides in the identified area.Surely, the spot radiation was obviously decided by your doctor because the cancer’s location was found and nobody ever can deny that this is not the only spot of cancer existing in you. The success of RT may free you from the bandit and from this forum forever.
Regarding the radiologist and radiation therapist skills I would look for the ones with experience in delivering spot radiation to identified targets. That does not mean that they should be PCa specialists. In any case you should procure the treatment in places with the latest modern facilities and equipments. Dattoli Cancer Center (Sarasota) is famous (and expensive) but I know of at least one case of bad practice that leaved a PCa patient with nasty results and without post therapy assistance. You got time to find a satisfactory place.
Best wishes for your continuing journey.
VGama
NOTE: the trip from Australia to the USA may be through Europe. How about a glass of Portuguese red at Quinta-do-Lago?
0 -
Note to TravelerVascodaGama said:SUV 7.7 in cancer producing low serum PSA
Traveler
Thanks for the update. I am very curious and interested in your follow-ups because, though differently, I am behind you on the same “route” of testing and treatment (if I can afford it). Please excuse my opinions if they do not correspond to your decisions. In any case I accept your challenging invitation for comments and suggestions.
I think that you did well in starting your next phase of treatment because of your Gs7 and past PSA histology and events. However, the PSA level of 1.5 may have been too low (the threshold) to get the F18 FCH PET. Probably you may have reflected differently if the aggressivity was lower.
I see a series of facts that in my case with a diagnosed Gs6 I will consider before advancing with the PET/CT. One is the curve of the PSA. Sudden rises do not mean bigger volumes that may accommodate better scanning. A constant level is more indicative of volumetric tumours.
As you commented, the F18 Fluoromethyl choline PET/CT study (F18 FCH) got limits in detecting smaller volumes of malignancy (micromets). Studies show that this choline analogue (fluorocholine) manages to pinpoint volumes with a mean SUVmax between 6.0 to 2.0. But benign tissues that can produce SUV of 4.0 may cause false positives in the presence of malignancies of lower SUV 2.0.
Your test revealed an area with SUV 7.7 which may be judged extraordinary elevated for a low PSA of 1.5. This tells me that your cancer cells are of the type that uptake well the contrast agent even in the low PSA “environment”. The fact takes me to believe that the “whole” existing cancer resides in the identified area.Surely, the spot radiation was obviously decided by your doctor because the cancer’s location was found and nobody ever can deny that this is not the only spot of cancer existing in you. The success of RT may free you from the bandit and from this forum forever.
Regarding the radiologist and radiation therapist skills I would look for the ones with experience in delivering spot radiation to identified targets. That does not mean that they should be PCa specialists. In any case you should procure the treatment in places with the latest modern facilities and equipments. Dattoli Cancer Center (Sarasota) is famous (and expensive) but I know of at least one case of bad practice that leaved a PCa patient with nasty results and without post therapy assistance. You got time to find a satisfactory place.
Best wishes for your continuing journey.
VGama
NOTE: the trip from Australia to the USA may be through Europe. How about a glass of Portuguese red at Quinta-do-Lago?
T,You seem to be well informed about your status and I was impressed with the info you documented to date. For the record, my intent in asking questions about your diagnostic imaging was sincere and based on your invitation for comments and thoughts about the info you posted. If I misinterpreted your request or my questions were somehow misplaced, then please forgive me. My intent was simply to confirm my understanding of the info you shared (from your perspective) and in doing so, I hoped to learn more about your recent choices and decisions. Perhaps others might also. The questions I posed did NOT have anything whatsoever to do with 2nd guessing the path you've elected going forward. Surely the situation that you're coping with is stressful enough. If in any way I infringed upon your thread, then please know that was never the intent.I hope the info I provided about Dr King, the radiation oncologist (RO) in SoCal, proves to be helpful to you or others. As before, I wish you all the best as your journey continues.mrs pjd0 -
mrdpjdmrspjd said:Note to Traveler
T,You seem to be well informed about your status and I was impressed with the info you documented to date. For the record, my intent in asking questions about your diagnostic imaging was sincere and based on your invitation for comments and thoughts about the info you posted. If I misinterpreted your request or my questions were somehow misplaced, then please forgive me. My intent was simply to confirm my understanding of the info you shared (from your perspective) and in doing so, I hoped to learn more about your recent choices and decisions. Perhaps others might also. The questions I posed did NOT have anything whatsoever to do with 2nd guessing the path you've elected going forward. Surely the situation that you're coping with is stressful enough. If in any way I infringed upon your thread, then please know that was never the intent.I hope the info I provided about Dr King, the radiation oncologist (RO) in SoCal, proves to be helpful to you or others. As before, I wish you all the best as your journey continues.mrs pjd
i am sorry for themrdpjd
i am sorry for the delay in responding, i have been on the move and away from my computer. Firstly you have no need to apologise your advice was most welcome.
On the question raised, my earlier scan (post triple blockade ) was a C11 Choline /acitiate though as my files are in transit i cant give you the exact detail. We opted for the F18 this time based on a view that there were less false positives on low PSA with this marker. Again i cant quote the studies.
On next steps after discussing this with my MO (Dr Tucker) we have opted to use UCLA , my discs arrived there this morning and i am due to have a conf call with them in the next few days to discuss treatment plans. This is with Dr's Steinber, Kaplin and Cox , so i think i am in good hands and Dr Tucker who i have great respect for knows them and as he hails from LA we chose them over Dattoli.
Vasco
Thanks for your again insightful comments , and i am hoping that the plan in development allows me to have a sucessful outcome.
Not sure if my route will take me via Europe but if it does i will make sure i drop in at the Algarve for that glass of red to celebrate your good news.
I will keep you posted.
Many thanks to all for your assistance and comments.
Happy holidays
0 -
UCLA etctraveler said:mrdpjd
i am sorry for themrdpjd
i am sorry for the delay in responding, i have been on the move and away from my computer. Firstly you have no need to apologise your advice was most welcome.
On the question raised, my earlier scan (post triple blockade ) was a C11 Choline /acitiate though as my files are in transit i cant give you the exact detail. We opted for the F18 this time based on a view that there were less false positives on low PSA with this marker. Again i cant quote the studies.
On next steps after discussing this with my MO (Dr Tucker) we have opted to use UCLA , my discs arrived there this morning and i am due to have a conf call with them in the next few days to discuss treatment plans. This is with Dr's Steinber, Kaplin and Cox , so i think i am in good hands and Dr Tucker who i have great respect for knows them and as he hails from LA we chose them over Dattoli.
Vasco
Thanks for your again insightful comments , and i am hoping that the plan in development allows me to have a sucessful outcome.
Not sure if my route will take me via Europe but if it does i will make sure i drop in at the Algarve for that glass of red to celebrate your good news.
I will keep you posted.
Many thanks to all for your assistance and comments.
Happy holidays
Tra
Thanks. Prior to your recent F18 FCH PET/CT study, it’s a little unclear exactly which specific diagnostic imaging studies you’ve had and when (timeline), corresponding to PSA values pre ADT3, IADT3 on-cycle, and IADT off-cycle while on Proscar.You noted that Proscar was continued and Leukine started in the IADT off-cycle. 5-ARIs such as Proscar and Avodart are known to decrease PSA levels by approx 50%. If on Proscar when the F18 FCH imaging was done Dec 13, your adjusted PSA value actually may have been higher than 1.563, possibly double, +/-3. I wonder if this might explain the high uptake value in the context of a “seemingly low” PSA (<2) when the test was taken.
Apparently, the F18 FCH study confirmed a lesion on the left ischium, the same location that a previous imaging study (perhaps the C11 acetate PET/CT) found a suspicious spot post ADT3, but sometime before the F18 FCH study, and also at a “low” PSA value while off ADT and on Proscar. You indicated “this is the same spot where something was identified in a scan I had at Sloane Kettering in 2011 but it was to small to be certain of its type or nature.” And also wrote “In June 2011 (aged 60) I started CAB my PSA was 1 at that time, prior to the start of hormone treatment I undertook PET/CT scans all of which were clear.” And, “…my earlier scan (post triple blockade) was a C11 Choline /acitiate...” I wonder if/when an F18 Na (sodium) PET/CT study was ever done and if so, how the findings compared with those of the F18 FCH. It's a good idea to retain copies of your PCa medical records for your personal files and reference.
With one “hot spot” identified and the fact that you’re asymptomatic for SRE (Skeletal Related Events), the hope is that targeted RT would be with curative intent, rather than palliative. However, as you’ve commented, and I agree “…I’m a realist and know that this may just be the largest of a number of micro mets not yet identifiable.” Xofigo (aka Alpharadin, Radium 223) was FDA approved this year with a specific indication for late-stage, castration-resistant PCa with metastases in bone but not other organs. This option may be a consideration down the road and worth a current discussion with Tucker or PCa oncologists in the States.
Your concerns about the potential for rads on rads toxicity and/or collateral tissue damage are real and understandable due to your previous SRT post RP and the anatomical location of the lesion. It’s wise to seek a team of experienced world class ROs & radiologists at a medical center of excellence, such as UCLA, to evaluate both the efficacy and safety of targeted radiation to the spot identified on the left pelvic base. After suggesting Dr King at UCLA, you indicated an upcoming phone consult was scheduled with Steinberg, Cox and Kaplin at UCLA. Steinberg is well known. What are the specialties and department affiliations for Cox and Kaplin at UCLA?
Dr Michael Steinberg, FASTRO, FACR, FACRO, is Chair of the UCLA Department of Radiation Oncology. IMHO, he has assembled a world class RO dept by recruiting the best and the brightest in the field of radiation oncology to form a world class "brain trust" of RO experts at UCLA (including Drs King, Kupelian and others). Steinberg, collaborating with his RO team and radiologists, will evaluate your imaging studies & medical history to determine if the location of the isolated met can be safely/effectively targeted with either SBRT or IMRT. Unlike some other RO clinics that offer IMRT but not SBRT, UCLA’s medical center has both IMRT and SBRT technology available in its RT arsenal, as well as other forms of RT. Dr Chris King, formerly at Stanford, is best known for his work with SBRT and, if SBRT is indicated, he may oversee dosimetric planning.As you’re aware, restarting the ADT cycle on Dec 16 may lower PSA and shrink the current lesion over the next 4 months, making it less well defined on any subsequent image study taken in March, when you plan to travel for possible tx. Advanced imaging studies like the C11 Choline or acetate, taken at low PSA values (</=2) may make findings unreliable and it is often recommended that the patient be off ADT at the time of C11 Choline or acetate scans. However, I understand your decision to restart ADT and the double edged sword dilemma if you didn’t. With this in mind, even with the pelvic met “area mapped out” or outlined on films from the December F18 FCH study, most medical professionals/institutions, including the UCLA team, will likely require that you undergo an advanced imaging study, such as a C11 acetate PET/CT, at their medical center prior to any tx they provide. This is necessary for optimum therapeutic RT planning in order to compare, verify and confirm the findings from other medical institutions. Precise target planning and dosing are critical to avoid an undesirable outcome of over or under tx. An imaging study prior to tx may identify adjacent areas of involvement that could make focal RT impossible without risking collateral tissue damage & serious side effects. Or, it could identify other suspicious lesions that also might be candidates for targeted RT.
It’s important to understand and consider all factors that make up the big picture with PCa, as you’re doing. Here’s hoping that the location of the isolated lesion(s) can be focally tx’d and the outcome is successful.
Best,
mrs pjd
wife of a T3 stage PCa survivor
0 -
Next Stepsmrspjd said:UCLA etc
Tra
Thanks. Prior to your recent F18 FCH PET/CT study, it’s a little unclear exactly which specific diagnostic imaging studies you’ve had and when (timeline), corresponding to PSA values pre ADT3, IADT3 on-cycle, and IADT off-cycle while on Proscar.You noted that Proscar was continued and Leukine started in the IADT off-cycle. 5-ARIs such as Proscar and Avodart are known to decrease PSA levels by approx 50%. If on Proscar when the F18 FCH imaging was done Dec 13, your adjusted PSA value actually may have been higher than 1.563, possibly double, +/-3. I wonder if this might explain the high uptake value in the context of a “seemingly low” PSA (<2) when the test was taken.
Apparently, the F18 FCH study confirmed a lesion on the left ischium, the same location that a previous imaging study (perhaps the C11 acetate PET/CT) found a suspicious spot post ADT3, but sometime before the F18 FCH study, and also at a “low” PSA value while off ADT and on Proscar. You indicated “this is the same spot where something was identified in a scan I had at Sloane Kettering in 2011 but it was to small to be certain of its type or nature.” And also wrote “In June 2011 (aged 60) I started CAB my PSA was 1 at that time, prior to the start of hormone treatment I undertook PET/CT scans all of which were clear.” And, “…my earlier scan (post triple blockade) was a C11 Choline /acitiate...” I wonder if/when an F18 Na (sodium) PET/CT study was ever done and if so, how the findings compared with those of the F18 FCH. It's a good idea to retain copies of your PCa medical records for your personal files and reference.
With one “hot spot” identified and the fact that you’re asymptomatic for SRE (Skeletal Related Events), the hope is that targeted RT would be with curative intent, rather than palliative. However, as you’ve commented, and I agree “…I’m a realist and know that this may just be the largest of a number of micro mets not yet identifiable.” Xofigo (aka Alpharadin, Radium 223) was FDA approved this year with a specific indication for late-stage, castration-resistant PCa with metastases in bone but not other organs. This option may be a consideration down the road and worth a current discussion with Tucker or PCa oncologists in the States.
Your concerns about the potential for rads on rads toxicity and/or collateral tissue damage are real and understandable due to your previous SRT post RP and the anatomical location of the lesion. It’s wise to seek a team of experienced world class ROs & radiologists at a medical center of excellence, such as UCLA, to evaluate both the efficacy and safety of targeted radiation to the spot identified on the left pelvic base. After suggesting Dr King at UCLA, you indicated an upcoming phone consult was scheduled with Steinberg, Cox and Kaplin at UCLA. Steinberg is well known. What are the specialties and department affiliations for Cox and Kaplin at UCLA?
Dr Michael Steinberg, FASTRO, FACR, FACRO, is Chair of the UCLA Department of Radiation Oncology. IMHO, he has assembled a world class RO dept by recruiting the best and the brightest in the field of radiation oncology to form a world class "brain trust" of RO experts at UCLA (including Drs King, Kupelian and others). Steinberg, collaborating with his RO team and radiologists, will evaluate your imaging studies & medical history to determine if the location of the isolated met can be safely/effectively targeted with either SBRT or IMRT. Unlike some other RO clinics that offer IMRT but not SBRT, UCLA’s medical center has both IMRT and SBRT technology available in its RT arsenal, as well as other forms of RT. Dr Chris King, formerly at Stanford, is best known for his work with SBRT and, if SBRT is indicated, he may oversee dosimetric planning.As you’re aware, restarting the ADT cycle on Dec 16 may lower PSA and shrink the current lesion over the next 4 months, making it less well defined on any subsequent image study taken in March, when you plan to travel for possible tx. Advanced imaging studies like the C11 Choline or acetate, taken at low PSA values (</=2) may make findings unreliable and it is often recommended that the patient be off ADT at the time of C11 Choline or acetate scans. However, I understand your decision to restart ADT and the double edged sword dilemma if you didn’t. With this in mind, even with the pelvic met “area mapped out” or outlined on films from the December F18 FCH study, most medical professionals/institutions, including the UCLA team, will likely require that you undergo an advanced imaging study, such as a C11 acetate PET/CT, at their medical center prior to any tx they provide. This is necessary for optimum therapeutic RT planning in order to compare, verify and confirm the findings from other medical institutions. Precise target planning and dosing are critical to avoid an undesirable outcome of over or under tx. An imaging study prior to tx may identify adjacent areas of involvement that could make focal RT impossible without risking collateral tissue damage & serious side effects. Or, it could identify other suspicious lesions that also might be candidates for targeted RT.
It’s important to understand and consider all factors that make up the big picture with PCa, as you’re doing. Here’s hoping that the location of the isolated lesion(s) can be focally tx’d and the outcome is successful.
Best,
mrs pjd
wife of a T3 stage PCa survivor
Mrs Pjd firstly let me apologize for misspelling your name in my last response, I was clearly having a bad day at the keyboard in a number of ways (misspelling other names and incorrectly naming others in that posting, end of year fatigue maybe!). You make some good points about my scans and the impact of Proscar on both the scans and my PSA. The scans I had at Sloane Kettering were pre any hormone treatment and with a PSA of 1 so not surprising the matter identified was not clear enough to be classified. At time they recommended an endorectal MRI to be done and fused with the CT/PET if radiation was to be considered. I can confirm that I am now scheduled to go to UCLA on Jan 21st and will begin simulation and consultation. I understand that to name Dr’s on the forum is frowned upon but I am seeing all 3 of the Dr;s you mentioned. I requested that they all be involved in either setting the treatment program or reviewing it and allowing me to discuss it with each of them, and they were fine with this approach. On the basis of an initial review of the Dec 16th scan the feedback from UCLA is I will need 1-3 treatments to sterilize the lesion ,prior to treatment the planning/ simulations will involve having an endorectal MRI and may require further PET/CT depending on what the fused images show. In the course of email exchanges /discussions on timing (including with my MO)it has been agreed that treating sooner might be better and certainly no worse than waiting until end of March. The plan is that on the 21st Jan I start the consultation / simulation process which will take 3-5 days and the treatment will flow on immediately following, so hopefully by the end of Jan I will be finished. Clearly I will remain on ADT3 until Dec 2014 and hopefully my PSA will drop to undetectable in the next 3 months and remain that way during the “on phase”. Once I go to the next off stage we will then be able to see if the program was successful. To be honest my biggest concern remains the side effects of rad on rad and that is an area where I will be focusing my questioning when in LA. I will keep you posted on nest steps on my journey. A Happy New Year to everyone Kind regards Traveler
0 -
Update 2014traveler said:Next Steps
Mrs Pjd firstly let me apologize for misspelling your name in my last response, I was clearly having a bad day at the keyboard in a number of ways (misspelling other names and incorrectly naming others in that posting, end of year fatigue maybe!). You make some good points about my scans and the impact of Proscar on both the scans and my PSA. The scans I had at Sloane Kettering were pre any hormone treatment and with a PSA of 1 so not surprising the matter identified was not clear enough to be classified. At time they recommended an endorectal MRI to be done and fused with the CT/PET if radiation was to be considered. I can confirm that I am now scheduled to go to UCLA on Jan 21st and will begin simulation and consultation. I understand that to name Dr’s on the forum is frowned upon but I am seeing all 3 of the Dr;s you mentioned. I requested that they all be involved in either setting the treatment program or reviewing it and allowing me to discuss it with each of them, and they were fine with this approach. On the basis of an initial review of the Dec 16th scan the feedback from UCLA is I will need 1-3 treatments to sterilize the lesion ,prior to treatment the planning/ simulations will involve having an endorectal MRI and may require further PET/CT depending on what the fused images show. In the course of email exchanges /discussions on timing (including with my MO)it has been agreed that treating sooner might be better and certainly no worse than waiting until end of March. The plan is that on the 21st Jan I start the consultation / simulation process which will take 3-5 days and the treatment will flow on immediately following, so hopefully by the end of Jan I will be finished. Clearly I will remain on ADT3 until Dec 2014 and hopefully my PSA will drop to undetectable in the next 3 months and remain that way during the “on phase”. Once I go to the next off stage we will then be able to see if the program was successful. To be honest my biggest concern remains the side effects of rad on rad and that is an area where I will be focusing my questioning when in LA. I will keep you posted on nest steps on my journey. A Happy New Year to everyone Kind regards Traveler
Update: Following the identification of a lesion on my left pubic ramus and in consultation with my MO in Singapore we decided that radiating this single lesion was an important step in my treatment program. In discussion with my MO and advice from some fellow CSN members I zeroed in on UCLA and the Oncology unit led by Dr Michael Steinberg as the destination for this treatment program. After referral and many emails back and forth on my medical history and a conference call with UCLA my treatment program was quickly scheduled. On arrival in LA on day 1(JAN 22 2014) I was seen by Dr Steinberg and his team to discuss the program they would enact I also I had an MRI in the afternoon. On day 2 the team then fused the MRI with my PET/CT scans from Singapore and ran simulations to obtain the best treatment option that would cause minimum damage to surrounding areas while sterilizing the lesion. On Day 3 , I met with Dr Sreinberg and his team and they ran me through the options they had modeled and outlined how they arrived at the solution they intended to follow. It involved SBRT of 36Gy being delivered over 3 days from 6 angles. They were terrific in their approach and the discussion of the detail involved in the analysis. The treatment was started on Day 3 and second treatment was Day 4, I then had a weekend off and had the third treatment on day 7 (a Monday) and flew out from LAX that evening. To date I have had no side effects from the treatment.
I have been back on the “on phase” of my hormone treatment starting on December 16th when my PSA was 1.59, I had my blood taken on Jan 30th and my PSA is now 0.044 and my T has fallen from 23 to 0.39.
In this “on phase” we have substituted casodex with xtandi , and maintained the same approach as my first hormone treatment program utilizing Proscar daily along with Zolodex every 3 months, In addition celebrax 200 mg daily and will restart my supplement program later this month (these were halted during the radiation treatment). Though it is early in on the “on phase” I have not had too many side effects, some hot flushes and night sweats but not to an extent that these cause discomfort or problems.
I have discussed with my MO how long we will make the “on phase” and have agreed we will monitor progress and will decided if we keep it to 12 months as per the last cycle or stop after 9 months this time.
I am a realist and know that while only one spot showed up on the PET/CT scans there are likely more micro mets but I am also an optimist and live in hope that having hit this one spot hard ,along with a CAB regime and a healthy lifestyle I can give it my best shot at beating the bandit !!
My focus is now on exercise and diet to help maintain my overall health and well being. I have also recently sold my business so this year is going to be one where I spend less time on airplanes and more time with my wife, although we do intend to travel albeit and a more leisurely pace then when I was running my company.
I would like to thank those members who have given me guidance and advice as I evaluated the options I had as I set off on this latest course of treatment all your help has been greatly appreciated.
I wish everyone the best in their battles with the bandit and success in programs you choose to follow.
I will continue to up date the outputs from my tests as I go thru the next few quarters.
Best Traveler
0 -
Done in styletraveler said:Update 2014
Update: Following the identification of a lesion on my left pubic ramus and in consultation with my MO in Singapore we decided that radiating this single lesion was an important step in my treatment program. In discussion with my MO and advice from some fellow CSN members I zeroed in on UCLA and the Oncology unit led by Dr Michael Steinberg as the destination for this treatment program. After referral and many emails back and forth on my medical history and a conference call with UCLA my treatment program was quickly scheduled. On arrival in LA on day 1(JAN 22 2014) I was seen by Dr Steinberg and his team to discuss the program they would enact I also I had an MRI in the afternoon. On day 2 the team then fused the MRI with my PET/CT scans from Singapore and ran simulations to obtain the best treatment option that would cause minimum damage to surrounding areas while sterilizing the lesion. On Day 3 , I met with Dr Sreinberg and his team and they ran me through the options they had modeled and outlined how they arrived at the solution they intended to follow. It involved SBRT of 36Gy being delivered over 3 days from 6 angles. They were terrific in their approach and the discussion of the detail involved in the analysis. The treatment was started on Day 3 and second treatment was Day 4, I then had a weekend off and had the third treatment on day 7 (a Monday) and flew out from LAX that evening. To date I have had no side effects from the treatment.
I have been back on the “on phase” of my hormone treatment starting on December 16th when my PSA was 1.59, I had my blood taken on Jan 30th and my PSA is now 0.044 and my T has fallen from 23 to 0.39.
In this “on phase” we have substituted casodex with xtandi , and maintained the same approach as my first hormone treatment program utilizing Proscar daily along with Zolodex every 3 months, In addition celebrax 200 mg daily and will restart my supplement program later this month (these were halted during the radiation treatment). Though it is early in on the “on phase” I have not had too many side effects, some hot flushes and night sweats but not to an extent that these cause discomfort or problems.
I have discussed with my MO how long we will make the “on phase” and have agreed we will monitor progress and will decided if we keep it to 12 months as per the last cycle or stop after 9 months this time.
I am a realist and know that while only one spot showed up on the PET/CT scans there are likely more micro mets but I am also an optimist and live in hope that having hit this one spot hard ,along with a CAB regime and a healthy lifestyle I can give it my best shot at beating the bandit !!
My focus is now on exercise and diet to help maintain my overall health and well being. I have also recently sold my business so this year is going to be one where I spend less time on airplanes and more time with my wife, although we do intend to travel albeit and a more leisurely pace then when I was running my company.
I would like to thank those members who have given me guidance and advice as I evaluated the options I had as I set off on this latest course of treatment all your help has been greatly appreciated.
I wish everyone the best in their battles with the bandit and success in programs you choose to follow.
I will continue to up date the outputs from my tests as I go thru the next few quarters.
Best Traveler
Traveller
I am so happy for you. Your facts are great news and the conclusive results are on the target to a positive success.
The radiation hit the bull’s eyes. This was your intention and you just did it. And more than that, you did it in style with the whole ingredients.I want firstly to thank you for the update and for the details. It surely will help me and the many in similar situations. Reading your story is inspiring and a spring of hope to us all.
The decrease of the PSA is consistent with previous outcomes. We do not know how much of the decline is due to RT or how much is due to HT but in spot radiations in bone one expects the PSA to decline fast and it did.
In 2007 before surgery the PSA was 8.9 and it got down to 0.02. This was indicative that the bulk has been removed. This time you may have killed the remaining cells.I hope for your continuing remission and expect to read your good news again at the end of HT.
Best wishes,
VGama
Note; I believe you indicated the testosterone in nmol/L unit value. This equals to a decline from 23=662 ng/dL to 0.39=11 ng/dL.
0 -
Thanks for great informationVascodaGama said:Done in style
Traveller
I am so happy for you. Your facts are great news and the conclusive results are on the target to a positive success.
The radiation hit the bull’s eyes. This was your intention and you just did it. And more than that, you did it in style with the whole ingredients.I want firstly to thank you for the update and for the details. It surely will help me and the many in similar situations. Reading your story is inspiring and a spring of hope to us all.
The decrease of the PSA is consistent with previous outcomes. We do not know how much of the decline is due to RT or how much is due to HT but in spot radiations in bone one expects the PSA to decline fast and it did.
In 2007 before surgery the PSA was 8.9 and it got down to 0.02. This was indicative that the bulk has been removed. This time you may have killed the remaining cells.I hope for your continuing remission and expect to read your good news again at the end of HT.
Best wishes,
VGama
Note; I believe you indicated the testosterone in nmol/L unit value. This equals to a decline from 23=662 ng/dL to 0.39=11 ng/dL.
I would like to thank Traveler, Mrspjd, and VascodaGama for their comprehensive and insightful information about Traveler's treatment. I have been undergoing HT for the past six months and, after experiencing PSA less than .008 for that time, have just seen a rise in the PSA indicating that at least a portion of the Pc has become hormone indepent. The various posts in this string have given me excellent options which I will be discussing with my oncologist.
0 -
3 Months updatenuclearduck said:Thanks for great information
I would like to thank Traveler, Mrspjd, and VascodaGama for their comprehensive and insightful information about Traveler's treatment. I have been undergoing HT for the past six months and, after experiencing PSA less than .008 for that time, have just seen a rise in the PSA indicating that at least a portion of the Pc has become hormone indepent. The various posts in this string have given me excellent options which I will be discussing with my oncologist.
Firstly many thanks for the kind words, advice and encouragement from all especially VG who is unbelievable and tireless in his support too so many on the journey we all find ourselves on.
It is now 3 months since I started my second "on phase" of IHT and 6 weeks since my SBRT session at UCLA.
My latest blood tests have shown my PSA at 0.01 down from 0.04 in Feb, I had a bounce in my T to 1.8 but this occurred at the 3 month point in my first “on phase” and then dropped back so I expect the same to happen this time.
My cholesterol has risen but I had to switch from Lipitor to Crestor because of the interaction with Xtandi and in doing so dropped from 20mg to 10 mg so I am now going back up to 20mg. My family has a terrible history of heart disease so regardless of diet and exercise I am genetically predisposed to high cholesterol, something i need to keep a careful watch on.
The good news also, is my CTC (circulating tumor cell) score has been “0” for 3 months in a row, while it is not perfect test it is a positive indicator.
I am continuing with my exercise program and have lost 1 kilo and while that might not seem much, in the prior cycle I gained 6kgs in the first 3 months so I am hoping I can keep the weight gain out of the picture this time around and more importantly I have not had to ban red wine to do this, which is always a bonus!
I have had my second Zoladex 3 month shot yesterday and will post and update in 3 months time at the half way point of this second "on phase" of IHT.
Once again thanks again to everyone for your support and good luck on your individual battles with the Bandit!!
T
0 -
Yet another excellent updatetraveler said:3 Months update
Firstly many thanks for the kind words, advice and encouragement from all especially VG who is unbelievable and tireless in his support too so many on the journey we all find ourselves on.
It is now 3 months since I started my second "on phase" of IHT and 6 weeks since my SBRT session at UCLA.
My latest blood tests have shown my PSA at 0.01 down from 0.04 in Feb, I had a bounce in my T to 1.8 but this occurred at the 3 month point in my first “on phase” and then dropped back so I expect the same to happen this time.
My cholesterol has risen but I had to switch from Lipitor to Crestor because of the interaction with Xtandi and in doing so dropped from 20mg to 10 mg so I am now going back up to 20mg. My family has a terrible history of heart disease so regardless of diet and exercise I am genetically predisposed to high cholesterol, something i need to keep a careful watch on.
The good news also, is my CTC (circulating tumor cell) score has been “0” for 3 months in a row, while it is not perfect test it is a positive indicator.
I am continuing with my exercise program and have lost 1 kilo and while that might not seem much, in the prior cycle I gained 6kgs in the first 3 months so I am hoping I can keep the weight gain out of the picture this time around and more importantly I have not had to ban red wine to do this, which is always a bonus!
I have had my second Zoladex 3 month shot yesterday and will post and update in 3 months time at the half way point of this second "on phase" of IHT.
Once again thanks again to everyone for your support and good luck on your individual battles with the Bandit!!
T
Traveler
It feels good to read your good news. I hope you return again in three months time with yet another excellent update.
You have not shared your treatment protocol in this second "on phase" of IHT. Is there any fixed period for the use of Zoladex? What are the other meds you are taking?
Regarding statins, I am taking on/off periods of Sinvastatine (20mg/day). I knew of meds interactions but thought that the typical statins taken in lower doses would be OK with Xtandi. Thanks for mentioning about your experience with Crestor. Dr. Myers also advice Crestor (rosuvastatin ) for guys taking Zytiga with the intent to help Zytiga in being more efficient in blocking the CYP17A1 used by the cancer to produce own testosterone. In other words, high cholesterol (LLD) goes hand in hand with HT refractory.
Due to your risk (family history) of high cholesterol related problems, you may be interested in listen to Myers video explaining about the effect of High Cholesterol, Cancer and Zytiga. Here is the link;
http://askdrmyers.wordpress.com/?mkt_tok=3RkMMJWWfF9wsRonvajBZKXonjHpfsXx6OosT/rn28M3109ad+rmPBy+24MIWp8na+qWCgseOrQ8lV4JV8e/Us0RraQ=In this link you can also read about the opinions of statins users comparing Crestor with others;
http://www.medhelp.org/posts/Heart-Disease/Crestor--vs--Simvastatin/show/1420140Red Australia wine, yes yes……….., I had it and paid many corkage-fees in Sydney’s take-a-long restaurants.
Best wishes for complete recovery and a good final outcome.
VGama
0 -
UPDATE MARCH 2014VascodaGama said:Yet another excellent update
Traveler
It feels good to read your good news. I hope you return again in three months time with yet another excellent update.
You have not shared your treatment protocol in this second "on phase" of IHT. Is there any fixed period for the use of Zoladex? What are the other meds you are taking?
Regarding statins, I am taking on/off periods of Sinvastatine (20mg/day). I knew of meds interactions but thought that the typical statins taken in lower doses would be OK with Xtandi. Thanks for mentioning about your experience with Crestor. Dr. Myers also advice Crestor (rosuvastatin ) for guys taking Zytiga with the intent to help Zytiga in being more efficient in blocking the CYP17A1 used by the cancer to produce own testosterone. In other words, high cholesterol (LLD) goes hand in hand with HT refractory.
Due to your risk (family history) of high cholesterol related problems, you may be interested in listen to Myers video explaining about the effect of High Cholesterol, Cancer and Zytiga. Here is the link;
http://askdrmyers.wordpress.com/?mkt_tok=3RkMMJWWfF9wsRonvajBZKXonjHpfsXx6OosT/rn28M3109ad+rmPBy+24MIWp8na+qWCgseOrQ8lV4JV8e/Us0RraQ=In this link you can also read about the opinions of statins users comparing Crestor with others;
http://www.medhelp.org/posts/Heart-Disease/Crestor--vs--Simvastatin/show/1420140Red Australia wine, yes yes……….., I had it and paid many corkage-fees in Sydney’s take-a-long restaurants.
Best wishes for complete recovery and a good final outcome.
VGama
I am providing an update as I had blood tests early ahead of a long planned holiday, the next update wont be until June.
My PSA fell again to <0.008 which is the same low point it reached in my first round of IHT and my T dropped back to 0.9, my cholesterol also has started to fall after increasing the Crestor to 20mg.
In answer to VG's question, my medicine program now is as follows
· Xtandi 160mg per day
· Proscar 5mg per day
· Celebrex 200mg per day
· Zoladex (3 monthly)
· Xgeva 120mg (denosumab) monthly
· Supplements
o Curcumin 800mg per day
o Pomegranate 800mg per day
o Vitamin D3 3000 IU per day
o Fish oil 3000mg per day
o Resveratrol 250mg per day
o CoQ1O 100MG per day
o Calcium 600mg every second day
Right now I am feeling fine no side effects, I am having to work hard to force myself to exercise and focus on keeping my weight under control.
I had hoped to keep losing weight but have leveled out in the last 3 weeks.
Just to put this in perspective when I started the first phase of IHT I weighed 82kg, at the end of 12 months I was 94 kg , I am now back to 82kg and want to get back to 80kg and long term to 75kg ( my height is 1.75m).
While I have been walking circa 70-100k a week I need to focus on some resistance exercises to stop muscle wasting so while keeping weight under control is important it is also important to look at BMI to ensure muscle is not being replaced by fat.
Good luck and Best wishes to all on your respective journeys
Kind regards
T
0 -
At even-par
Traveler
Congratulations. I hope the stress has dissipated with these latest results. You are at even-par. Will you aim the birdies?
But …………… do you need more? You are a winner already.Thanks for sharing your treatment protocol. It seems to be the typical Total Blockade (ADT3) with Xtandi replacing Casodex. Both are antiandrogens but Xtandi is more “refined”. It works at intratumoral levels. The Celebrex (COX2 inhibitor) was big news back in 2006. The famous STAMPEDE trial for the use of this tumour growth inhibitor was incomplete in my view and has shown little effects, even at daily doses of 400mg, but some patients managed to get high points in the control of advanced PCa. At the time I checked about possibilities for my case of micro mets but opted to continue with the daily aspirin 100mg. Xgeva may have been added to the protocol to help in bone “repair” after radiation (???).
The list of supplements seems to be the best and complete. CoQ10 100MG become big news in 2005 after a Spanish trial have shown that CoQ10 managed to lower PCa cells growth without affecting cell growth in the non-malignant cell lines. Our buddy Charles (Chuck) Maack from the PCa support group at Us TOO has an interesting blog with the views of Dr. Myers and listed articles. I provide the link below to the many reading your thread and that may be interested in your treatment. The title is COQ-10 (COENZYME Q-10) – GOOD OR BAD?
http://www.ustoowichita.org/pdf/COQ-10 GOOD OR BAD .pdf
http://www.ustoowichita.org/The excellent outcome in this start of the second phase of IHT (with first line HT drugs) shows that you got “extra options” for the fight, would that become necessary. I hope you do not need it but I say this because of your concerns commented in your post above. You say;
“…I am a realist and know that while only one spot showed up on the PET/CT scans there are likely more micro mets but I am also an optimist …”
Any future PET/CT examination may give you peace of mind, in any case I believe that the spot RT eradicated the bandit and that now you should enjoy and engage in things you like doing best. Enjoy and celebrate.
Best
Vgama
0 -
A new update on IAD with XtandiVascodaGama said:At even-par
Traveler
Congratulations. I hope the stress has dissipated with these latest results. You are at even-par. Will you aim the birdies?
But …………… do you need more? You are a winner already.Thanks for sharing your treatment protocol. It seems to be the typical Total Blockade (ADT3) with Xtandi replacing Casodex. Both are antiandrogens but Xtandi is more “refined”. It works at intratumoral levels. The Celebrex (COX2 inhibitor) was big news back in 2006. The famous STAMPEDE trial for the use of this tumour growth inhibitor was incomplete in my view and has shown little effects, even at daily doses of 400mg, but some patients managed to get high points in the control of advanced PCa. At the time I checked about possibilities for my case of micro mets but opted to continue with the daily aspirin 100mg. Xgeva may have been added to the protocol to help in bone “repair” after radiation (???).
The list of supplements seems to be the best and complete. CoQ10 100MG become big news in 2005 after a Spanish trial have shown that CoQ10 managed to lower PCa cells growth without affecting cell growth in the non-malignant cell lines. Our buddy Charles (Chuck) Maack from the PCa support group at Us TOO has an interesting blog with the views of Dr. Myers and listed articles. I provide the link below to the many reading your thread and that may be interested in your treatment. The title is COQ-10 (COENZYME Q-10) – GOOD OR BAD?
http://www.ustoowichita.org/pdf/COQ-10 GOOD OR BAD .pdf
http://www.ustoowichita.org/The excellent outcome in this start of the second phase of IHT (with first line HT drugs) shows that you got “extra options” for the fight, would that become necessary. I hope you do not need it but I say this because of your concerns commented in your post above. You say;
“…I am a realist and know that while only one spot showed up on the PET/CT scans there are likely more micro mets but I am also an optimist …”
Any future PET/CT examination may give you peace of mind, in any case I believe that the spot RT eradicated the bandit and that now you should enjoy and engage in things you like doing best. Enjoy and celebrate.
Best
Vgama
Hi everyone, I am a regular reader but have not posted for a while.
In my last post I had undergone SBRT for one met identified on my left ischium, this occurred at UCLA under Dr Steinberg a marvelous man and a marvelous institution.
At the same time I restarted IAD program consisting 3 month Zoledex, 160mg of Xtandi daily (as opposed to Casodex which I used in my first “on phase”) and 5mg Proscar.
As I mentioned in my last post my PSA dropped to <0.008 within 3 months (March 2014) and has remained there ever since.
I am now in my “off phase” having finished the hormone treatment in Dec 14. I still take proscar and inject Luekine 14 days on 14 days off, to stimulate my immune system.
During the last “on phase” my weight increased again, back up to 90kg and I noted muscle loss also.
Unfortunately I have injured my back and this has caused problems in my hip flexor and ITB that makes walking painful so my exercise regime has suffered. I am having Physio 3 times a week and things are improving but it is a slow business (over 3 months so far). I have detailed this because I feel that muscle loss is cumulative and we all know that past 40 it is harder to replace muscle and much harder past 60 (I am 64) but when you go through hormone treatment I now realize you have to do much more gym work on resistance exercises if you are going to arrest the decline.By this I mean 1-2 hrs daily for 3-4 days a week of some form of resistance exercise.
I had very little side effects during the on phase, at first the Xtandi made me tired but when I switched to taking it in the nighttime these side effects passed.
My hope is that I can last longer on this “off phase” than the last time but I am also a realist and know that the “bandit” in the form of dormant cancer cells is still likely lurking in some dark corner. The CTC count oscillating between 0 and 1 evidences this.
During the year I had the good fortune to meet Vasco and his beautiful wife in Portugal, he is as kind and considerate in person as he is in his virtual world.
I enjoyed his company and we discussed many of our shared experiences over fine food and wonderful red wine. I can tell you he is building a beautiful home in a wonderful orchard where he has planted many exotic fruit trees from his second country (Japan)
I hope to get the pleasure of meeting him again in the not to distant future.
I wish everyone the very best and I will continue to post updates on journey as we fight the Bandit!!
Best Wishes
T
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 396 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 538 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards